These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11343889)

  • 1. Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors.
    Gupta VK; Hariharan M; Wheatley TA; Price JC
    Eur J Pharm Biopharm; 2001 May; 51(3):241-8. PubMed ID: 11343889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled-release tablet matrices from carrageenans: compression and dissolution studies.
    Hariharan M; Wheatley TA; Price JC
    Pharm Dev Technol; 1997 Nov; 2(4):383-93. PubMed ID: 9552467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix tablets of carrageenans. II. Release behavior and effect of added cations.
    Picker KM
    Drug Dev Ind Pharm; 1999 Mar; 25(3):339-46. PubMed ID: 10071827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained release characteristics of tablets prepared with mixed matrix of sodium carrageenan and chitosan: effect of polymer weight ratio, dissolution medium, and drug type.
    Bani-Jaber A; Al-Ghazawi M
    Drug Dev Ind Pharm; 2005 Mar; 31(3):241-7. PubMed ID: 15830719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidation of release characteristics of highly soluble drug trimetazidine hydrochloride from chitosan-carrageenan matrix tablets.
    Li L; Wang L; Shao Y; Tian Y; Li C; Li Y; Mao S
    J Pharm Sci; 2013 Aug; 102(8):2644-54. PubMed ID: 23754467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix tablets based on a carrageenan with the modified-release of sodium riboflavin 5'-phosphate.
    Buchholcz G; Kelemen A; Sovány T; Pintye-Hódi K
    Pharm Dev Technol; 2015; 20(6):676-83. PubMed ID: 24758384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyelectrolyte-drug complexes of lambda carrageenan and basic drugs: relevance of particle size and moisture content on compaction and drug release behavior.
    Bonferoni MC; Sandri G; Rossi S; Ferrari F; Caramella C; Aguzzi C; Viseras C
    Drug Dev Ind Pharm; 2008 Nov; 34(11):1188-95. PubMed ID: 18720148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic degradation of cross-linked high amylose starch tablets and its effect on in vitro release of sodium diclofenac.
    Rahmouni M; Chouinard F; Nekka F; Lenaerts V; Leroux JC
    Eur J Pharm Biopharm; 2001 May; 51(3):191-8. PubMed ID: 11343882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes.
    Bonferoni MC; Rossi S; Ferrari F; Stavik E; Pena-Romero A; Caramella C
    AAPS PharmSciTech; 2000 Jun; 1(2):E15. PubMed ID: 14727848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive evaluation of pharmaceutical properties of direct compression tablets containing theophylline anhydrate during storage at high humidity by near-infrared spectroscopy.
    Otsuka Y; Yamamoto M; Tanaka H; Otsuka M
    Biomed Mater Eng; 2015; 25(3):223-36. PubMed ID: 26407109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of pentoxifylline from xanthan gum matrix tablets.
    El-Gazayerly ON
    Drug Dev Ind Pharm; 2003 Feb; 29(2):241-6. PubMed ID: 12648021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pH, buffer capacity and ionic strength on quetiapine fumarate release from matrix tablets prepared using two different polymeric blends.
    Hamed R; AlJanabi R; Sunoqrot S; Abbas A
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1330-1342. PubMed ID: 28402145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of oral controlled-release tablet formulations based on diltiazem-carrageenan complex.
    Bonferoni MC; Rossi S; Ferrari F; Caramella C
    Pharm Dev Technol; 2004; 9(2):155-62. PubMed ID: 15202574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.
    Korang-Yeboah M; Rahman Z; Shah D; Mohammad A; Wu S; Siddiqui A; Khan MA
    Int J Pharm; 2016 Feb; 499(1-2):20-28. PubMed ID: 26688036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the swelling behaviour of iota-carrageenan in monolithic matrix tablets.
    Kelemen A; Buchholcz G; Sovány T; Pintye-Hódi K
    J Pharm Biomed Anal; 2015 Aug; 112():85-8. PubMed ID: 25966465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation into the erosion behaviour of a high drug-load (85%) particulate system designed for an extended-release matrix tablet. Analysis of erosion kinetics in conjunction with variations in lubrication, porosity and compaction rate.
    Dürig T; Venkatesh GM; Fassihi R
    J Pharm Pharmacol; 1999 Oct; 51(10):1085-92. PubMed ID: 10579678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac.
    Piyakulawat P; Praphairaksit N; Chantarasiri N; Muangsin N
    AAPS PharmSciTech; 2007 Nov; 8(4):E97. PubMed ID: 18181557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrices of water-soluble drug using natural polymer and direct compression method.
    Rosario NL; Ghaly ES
    Drug Dev Ind Pharm; 2002 Sep; 28(8):975-88. PubMed ID: 12378966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release mechanism of doxazosin from carrageenan matrix tablets: Effect of ionic strength and addition of sodium dodecyl sulphate.
    Kos P; Pavli M; Baumgartner S; Kogej K
    Int J Pharm; 2017 Aug; 529(1-2):557-567. PubMed ID: 28648579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.